198 related articles for article (PubMed ID: 34322126)
1. Broad and Efficient Activation of Memory CD4
Höttler A; März L; Lübke M; Rammensee HG; Stevanović S
Front Immunol; 2021; 12():700438. PubMed ID: 34322126
[TBL] [Abstract][Full Text] [Related]
2. Discovery of immunodominant T-cell epitopes reveals penton protein as a second immunodominant target in human adenovirus infection.
Tischer S; Geyeregger R; Kwoczek J; Heim A; Figueiredo C; Blasczyk R; Maecker-Kolhoff B; Eiz-Vesper B
J Transl Med; 2016 Oct; 14(1):286. PubMed ID: 27717382
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous isolation of CD8(+) and CD4(+) T cells specific for multiple viruses for broad antiviral immune reconstitution after allogeneic stem cell transplantation.
Zandvliet ML; van Liempt E; Jedema I; Kruithof S; Kester MG; Guchelaar HJ; Falkenburg JH; Meij P
J Immunother; 2011 Apr; 34(3):307-19. PubMed ID: 21389867
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo detection of adenovirus specific CD4+ T-cell responses to HLA-DR-epitopes of the Hexon protein show a contracted specificity of T(HELPER) cells following stem cell transplantation.
Serangeli C; Bicanic O; Scheible MH; Wernet D; Lang P; Rammensee HG; Stevanovic S; Handgretinger R; Feuchtinger T
Virology; 2010 Feb; 397(2):277-84. PubMed ID: 19962170
[TBL] [Abstract][Full Text] [Related]
5. Identification and HLA-tetramer-validation of human CD4+ and CD8+ T cell responses against HCMV proteins IE1 and IE2.
Braendstrup P; Mortensen BK; Justesen S; Osterby T; Rasmussen M; Hansen AM; Christiansen CB; Hansen MB; Nielsen M; Vindeløv L; Buus S; Stryhn A
PLoS One; 2014; 9(4):e94892. PubMed ID: 24760079
[TBL] [Abstract][Full Text] [Related]
6. Major contribution of codominant CD8 and CD4 T cell epitopes to the human cytomegalovirus-specific T cell repertoire.
Nastke MD; Herrgen L; Walter S; Wernet D; Rammensee HG; Stevanović S
Cell Mol Life Sci; 2005 Jan; 62(1):77-86. PubMed ID: 15619009
[TBL] [Abstract][Full Text] [Related]
7. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
[TBL] [Abstract][Full Text] [Related]
8. Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-gamma-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation.
Hebart H; Daginik S; Stevanovic S; Grigoleit U; Dobler A; Baur M; Rauser G; Sinzger C; Jahn G; Loeffler J; Kanz L; Rammensee HG; Einsele H
Blood; 2002 May; 99(10):3830-7. PubMed ID: 11986243
[TBL] [Abstract][Full Text] [Related]
9. Co-ordinated isolation of CD8(+) and CD4(+) T cells recognizing a broad repertoire of cytomegalovirus pp65 and IE1 epitopes for highly specific adoptive immunotherapy.
Zandvliet ML; van Liempt E; Jedema I; Veltrop-Duits LA; Willemze R; Guchelaar HJ; Falkenburg JH; Meij P
Cytotherapy; 2010 Nov; 12(7):933-44. PubMed ID: 20078388
[TBL] [Abstract][Full Text] [Related]
10. Engineered HCMV-infected APCs enable the identification of new immunodominant HLA-restricted epitopes of anti-HCMV T-cell immunity.
Santamorena MM; Tischer-Zimmermann S; Bonifacius A; Mireisz CN; Costa B; Khan F; Kulkarni U; Lauruschkat CD; Sampaio KL; Stripecke R; Blasczyk R; Maecker-Kolhoff B; Kraus S; Schlosser A; Cicin-Sain L; Kalinke U; Eiz-Vesper B
HLA; 2024 Jun; 103(6):e15541. PubMed ID: 38923358
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-specific CD4+ T cell clones recognizing endogenous antigen inhibit viral replication in vitro through cognate interaction.
Heemskerk B; van Vreeswijk T; Veltrop-Duits LA; Sombroek CC; Franken K; Verhoosel RM; Hiemstra PS; van Leeuwen D; Ressing ME; Toes RE; van Tol MJ; Schilham MW
J Immunol; 2006 Dec; 177(12):8851-9. PubMed ID: 17142788
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
[TBL] [Abstract][Full Text] [Related]
13. Design of multi-epitope peptides containing HLA class-I and class-II-restricted epitopes derived from immunogenic Leishmania proteins, and evaluation of CD4+ and CD8+ T cell responses induced in cured cutaneous leishmaniasis subjects.
Hamrouni S; Bras-Gonçalves R; Kidar A; Aoun K; Chamakh-Ayari R; Petitdidier E; Messaoudi Y; Pagniez J; Lemesre JL; Meddeb-Garnaoui A
PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008093. PubMed ID: 32176691
[TBL] [Abstract][Full Text] [Related]
14. Normalizing ELISPOT responses to T-cell counts: a novel approach for quantification of HCMV-specific CD4(+) and CD8(+) T-cell responses in kidney transplant recipients.
Calarota SA; Chiesa A; Scaramuzzi L; Adzasehoun KM; Comolli G; Mangione F; Esposito P; Baldanti F
J Clin Virol; 2014 Sep; 61(1):65-73. PubMed ID: 24961915
[TBL] [Abstract][Full Text] [Related]
15. Long-term stable expanded human CD4+ T cell clones specific for human cytomegalovirus are distributed in both CD45RAhigh and CD45ROhigh populations.
Weekes MP; Wills MR; Sissons JG; Carmichael AJ
J Immunol; 2004 Nov; 173(9):5843-51. PubMed ID: 15494538
[TBL] [Abstract][Full Text] [Related]
16. Identification of HCMV-derived T cell epitopes in seropositive individuals through viral deletion models.
Lübke M; Spalt S; Kowalewski DJ; Zimmermann C; Bauersfeld L; Nelde A; Bichmann L; Marcu A; Peper JK; Kohlbacher O; Walz JS; Le-Trilling VTK; Hengel H; Rammensee HG; Stevanović S; Halenius A
J Exp Med; 2020 Mar; 217(3):. PubMed ID: 31869419
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo expansion of human cytomegalovirus-specific cytotoxic T cells by recombinant polyepitope: implications for HCMV immunotherapy.
Rist M; Cooper L; Elkington R; Walker S; Fazou C; Tellam J; Crough T; Khanna R
Eur J Immunol; 2005 Mar; 35(3):996-1007. PubMed ID: 15726667
[TBL] [Abstract][Full Text] [Related]
18. Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation.
Feuchtinger T; Matthes-Martin S; Richard C; Lion T; Fuhrer M; Hamprecht K; Handgretinger R; Peters C; Schuster FR; Beck R; Schumm M; Lotfi R; Jahn G; Lang P
Br J Haematol; 2006 Jul; 134(1):64-76. PubMed ID: 16803570
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the human cytomegalovirus pp65-directed T-cell response in healthy HLA-A2-positive individuals.
Schalich J; Vytvytska O; Zauner W; Fischer MB; Buschle M; Aichinger G; Klade CS
Biol Chem; 2008 May; 389(5):551-9. PubMed ID: 18953722
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo stimulation and expansion of both CD4(+) and CD8(+) T cells from peripheral blood mononuclear cells of human cytomegalovirus-seropositive blood donors by using a soluble recombinant chimeric protein, IE1-pp65.
Vaz-Santiago J; Lulé J; Rohrlich P; Jacquier C; Gibert N; Le Roy E; Betbeder D; Davignon JL; Davrinche C
J Virol; 2001 Sep; 75(17):7840-7. PubMed ID: 11483727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
